From the American Family Physician Blog:
Aggressively adjusting medication doses based on what may be inaccurate office BP readings could potentially cause patients significant harm. Most of the time, the JNC 8 guidelines are likely to be more applicable to the patients in our offices than SPRINT’s narrowly defined parameters.
No new hypertension guidelines have been issued since the publication of the SPRINT trial, but in August 2016, a majority of cardiologists at the European Society of Cardiology meeting gave a “thumbs down” to lowering blood pressure targets based on the trial’s results. An article published in Circulation explained how the measurement technique used in SPRINT would have led to blood pressure readings 5-10 mm Hg lower than in clinical practice.